Pediatric Asthma and Allergic Diseases: New Insights and Therapeutic Approaches

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Allergy and Immunology".

Deadline for manuscript submissions: 25 May 2026 | Viewed by 1003

Special Issue Editor


E-Mail Website
Guest Editor
Division of Pulmonology, Allergy & Sleep Medicine, Department of Pediatrics, Children’s Nebraska, Omaha, NE 68114, USA
Interests: asthma; allergic rhinitis; chronic sinusitis; food allergy; atopic dermatitis; eosinophilic esophagitis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Asthma and allergic diseases are common medical problems in the pediatric population. The rise in eosinophilic esophagitis as a relatively new disease highlights the complex interaction of genetics and the environment in inducing the development of a new allergic phenomenon.

Asthma, especially, along with all the other allergic diseases are rapidly being transformed into well-controlled and possibly developing remission using biologics. Evidence suggests biologics can postpone or stop the development of second or third allergic processes.

Less understood is non-allergic asthma in children, and its origins, therapy options and natural history. New investigations in small airway asthma using imaging, especially, and other non-invasive pulmonary testing, such as impulse oscillometry, are much less investigated in children and adolescents compared to adults.

Allergic rhinitis remains a large economic and population burden, especially in developed countries. Yet, a one-hundred-year-old therapy is still considered the mainstay.

Eosinophilic esophagitis and atopic dermatitis share common pathophysiology, and the utilization of biologics has revolutionized the therapy of these diseases. However, biologics are reserved for the most difficult cases and possess ambiguities pertaining to dosing and length of therapy that are not well reported from real-world observations.

These are a few of the many questions and circumstances facing medical providers and allergic disease specialists, which invites considerable continued investigation and medical reporting.

Thus, the Special Editor of the Allergy and Asthma Section seeks relevant publications on any of these or other pertinent allergy topics.

Prof. Dr. Russell Hopp
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatric
  • asthma
  • allergic diseases
  • eosinophilic esophagitis
  • atopic dermatitis
  • allergic rhinitis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

15 pages, 825 KB  
Systematic Review
Impedance Pneumography for Diagnosing and Monitoring Asthma in Young Children: A Systematic Review
by Sama-Rafie Hammod, Fanny Kullberg, Marie Hauerslev, Kirsten Skamstrup Hansen and Bo Chawes
Children 2026, 13(2), 193; https://doi.org/10.3390/children13020193 - 29 Jan 2026
Viewed by 747
Abstract
Background: Impedance pneumography (IP) is a non-invasive technique for assessing tidal breathing in young children and enables home-based recordings without active patient cooperation. By deriving tidal breathing flow–volume (TBFV) curves and indices such as the expiratory variability index (EVI), IP has been proposed [...] Read more.
Background: Impedance pneumography (IP) is a non-invasive technique for assessing tidal breathing in young children and enables home-based recordings without active patient cooperation. By deriving tidal breathing flow–volume (TBFV) curves and indices such as the expiratory variability index (EVI), IP has been proposed as a tool for identifying obstructive breathing patterns and monitoring airway function in early childhood. However, its clinical role in asthma and wheezing disorders has not been systematically evaluated. This review aimed to assess the evidence of IP in differentiating healthy children from those with asthma or recurrent wheeze, in reflecting treatment-related changes or acute bronchial obstruction, and in relation to other lung function tests. Methods: A systematic literature search of PubMed, Medline, Embase, and the Cochrane Library databases was conducted on 5 January 2026. Original studies using IP in children aged 0–7 years with asthma or wheeze were eligible. Study selection followed PRISMA guidelines, and risk of bias (RoB) was assessed using the Newcastle–Ottawa Scale (NOS). Due to substantial heterogeneity in study design, populations, and outcome measures, results were synthesized narratively. Results: Five studies were included, with a total of 376 participants aged 0.5–7.0 years. Three studies reported significantly lower EVI values and TBFV profile variation in children with asthma or recurrent wheeze compared with healthy controls. Two studies found an association between EVI and markers of airway obstruction. Changes in IP measures following inhaled corticosteroid treatment or medication withdrawal were reported, suggesting sensitivity to treatment-related changes. However, study quality was moderate to low, with small sample sizes, heterogeneous outcome definitions, and limited diagnostic validation. Conclusions: Current evidence suggests that IP-derived indices, particularly EVI, capture clinically relevant features of obstructive breathing patterns in young children and may be useful for longitudinal monitoring of airway function. However, evidence supporting a diagnostic role for IP in childhood asthma remains limited. Larger, independent, and methodologically robust studies are needed before IP can be integrated into routine clinical practice. Full article
Show Figures

Figure 1

Back to TopTop